IPTILBY

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Nov 2025 filing date already counts against anyone who files later.

Record

Serial number

79440400

Mark type

Word mark

Filed

12 Nov 2025

Published for opposition

24 Feb 2026

Attorney of record

Maury M. Tepper, III

Goods and services

• Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Owner

• Novartis AG, Basel, CH
• Novartis AG, Basel, CH

Prosecution history

• 25 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 25 Mar 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
• 25 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 25 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 25 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 25 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 24 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 24 Feb 2026 — PUBLISHED FOR OPPOSITION
• 19 Feb 2026 — NOTIFICATION PROCESSED BY IB
• 18 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 04 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 03 Feb 2026 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
• 27 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 25 Jan 2026 — ASSIGNED TO EXAMINER
• 16 Jan 2026 — APPLICATION FILING RECEIPT MAILED